Excellent for long-term metabolic health
This may be a lifelong commitment (and an expensive one) There are exceptions, but most people are likely to regain weight after stopping a GLP-1 drug
You cant calculate units correctly without this number
In Ontario and most other provinces, publicly funded coverage for semaglutide injections remains limited to type 2 diabetes, leaving patients who use the drugs for obesity to pay out of pocket or rely on private benefits, according to a report from The Canadian Press
Nat Clin Pract End Met 1:2231 Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987) Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
Liraglutide belongs to the GLP-1 receptor agonist class of drug, and current prescribing information for liraglutide products used in long-term weight management uses that 0.6 mg to 3 mg step-up schedule